» Articles » PMID: 9192266

Mutational Diversity and Hot Spots in the Alpha-sarcoglycan Gene in Autosomal Recessive Muscular Dystrophy (LGMD2D)

Overview
Journal J Med Genet
Specialty Genetics
Date 1997 Jun 1
PMID 9192266
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Sarcoglycanopathies are a genetically heterogeneous group of autosomal recessive muscular dystrophies in which the primary defect may reside in any of the genes coding for the different partners of the sarcolemmal sarcoglycan (SG) complex: the alpha-SG (LGMD2D at 17q21.2), the beta-SG (LGMD2E at 4q12), the gamma-SG (LGMD2C at 13q12), and the delta-SG (LGMD2F at 5q33). We report a series of 20 new unrelated families with 14 different mutations in the alpha-SG gene. Along with the mutations that we previously reported this brings our cohort of patients with alpha-sarcoglycanopathy to a total of 31 unrelated patients, carrying 25 different mutations. The missense mutations reside in the extracellular domain of the protein. Five of 15 missense mutations, carried by unrelated subjects on different haplotype backgrounds and of widespread geographical origins, account for 58% of the mutated chromosomes, with a striking prevalence of the R77C substitution (32%). The severity of the disease varies strikingly and correlates at least in part with the amount of residual protein and the type of mutation. The recurrent R284C substitution is associated with a benign disease course.

Citing Articles

Profiling of pathogenic variants in Japanese patients with sarcoglycanopathy.

Shimazaki R, Saito Y, Awaya T, Minami N, Kurosawa R, Hosokawa M Orphanet J Rare Dis. 2025; 20(1):1.

PMID: 39755676 PMC: 11699685. DOI: 10.1186/s13023-024-03521-2.


Structure and assembly of the dystrophin glycoprotein complex.

Wan L, Ge X, Xu Q, Huang G, Yang T, Campbell K Nature. 2024; 637(8048):1252-1260.

PMID: 39663450 DOI: 10.1038/s41586-024-08310-2.


Dual Blockade of Misfolded Alpha-Sarcoglycan Degradation by Bortezomib and Givinostat Combination.

Hoch L, Bourg N, Degrugillier F, Bruge C, Benabides M, Pellier E Front Pharmacol. 2022; 13:856804.

PMID: 35571097 PMC: 9093689. DOI: 10.3389/fphar.2022.856804.


Genotype-phenotype correlations in alpha-sarcoglycanopathy: a systematic review.

Carson L, Merrick D Ir J Med Sci. 2022; 191(6):2743-2750.

PMID: 35040091 DOI: 10.1007/s11845-021-02855-1.


A Journey with LGMD: From Protein Abnormalities to Patient Impact.

Georganopoulou D, Moisiadis V, Malik F, Mohajer A, Dashevsky T, Wuu S Protein J. 2021; 40(4):466-488.

PMID: 34110586 PMC: 8190568. DOI: 10.1007/s10930-021-10006-9.


References
1.
Tornaletti S, Pfeifer G . Complete and tissue-independent methylation of CpG sites in the p53 gene: implications for mutations in human cancers. Oncogene. 1995; 10(8):1493-9. View

2.
Kawai H, Akaike M, Endo T, Adachi K, Inui T, Mitsui T . Adhalin gene mutations in patients with autosomal recessive childhood onset muscular dystrophy with adhalin deficiency. J Clin Invest. 1995; 96(3):1202-7. PMC: 185739. DOI: 10.1172/JCI118152. View

3.
Piccolo F, Roberds S, Jeanpierre M, Leturcq F, Azibi K, Beldjord C . Primary adhalinopathy: a common cause of autosomal recessive muscular dystrophy of variable severity. Nat Genet. 1995; 10(2):243-5. DOI: 10.1038/ng0695-243. View

4.
Campbell K . Adhalin gene mutations and autosomal recessive limb-girdle muscular dystrophy. Ann Neurol. 1995; 38(3):353-4. DOI: 10.1002/ana.410380302. View

5.
Bushby K, Beckmann J . The limb-girdle muscular dystrophies--proposal for a new nomenclature. Neuromuscul Disord. 1995; 5(4):337-43. DOI: 10.1016/0960-8966(95)00005-8. View